Resultados da busca - Jeremy D. Kratz

  • Mostrando 1 - 5 resultados de 5
Refinar Resultados
  1. 1
    Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids

    Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids por Melissa C. Skala, Dustin A. Deming, Jeremy D. Kratz

    Publicado em 2022
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current Practice

    Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current Practice por Monica Arun Patel, Jeremy D. Kratz, Sam Joseph Lubner, Noelle K. LoConte, Nataliya V. Uboha

    Publicado em 2022
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble

    Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble por Andrew C. Stelzer, Aaron T. Frank, Jeremy D. Kratz, Michael D. Swanson, Marta J. Gonzalez-Hernandez, Jang Hyun Lee, Ioan Andricioaei, David M. Markovitz, Hashim M. Al‐Hashimi

    Publicado em 2011
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer

    Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer por Nataliya V. Uboha, Mustafa Basree, Jens C. Eickhoff, Dustin A. Deming, Kristina A. Matkowskyj, James D. Maloney, Daniel McCarthy, Malcolm M. DeCamp, Noelle K. LoConte, Philip B. Emmerich, Sean G. Kraus, Monica Arun Patel, Jeremy D. Kratz, Sam Joseph Lubner, Newton J. Hurst, M. Bassetti

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity

    Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity por Jeremy D. Kratz, Shujah Rehman, Katherine A. Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau, Cheri A. Pasch, Devon Miller, Lucas C. Zarling, Austin H. Yeung, Linda Clipson, Samantha J. Anderson, Alyssa K Steimle, Carley M. Sprackling, Kayla K. Lemmon, Daniel E. Abbott, Mark E. Burkard, M. Bassetti, Jens C. Eickhoff, Eugene F. Foley, Charles P. Heise, Randall J. Kimple, Elise H. Lawson, Noelle K. LoConte, Sam Joseph Lubner, Daniel Mulkerin, Kristina A. Matkowskyj, Cristina B. Sanger, Nataliya V. Uboha, Sean J. McIlwain, Irene M. Ong, Evie H. Carchman, Melissa C. Skala, Dustin A. Deming

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: